The 2020 Servier Golden Ticket awards a biotech focus on oncology
All the news from Servier Group
Servier Expands CAR-T Oncology Development Collaboration with Precision BioSciences
Hypertension: Servier launches a new edition of the public awareness campaign “Because I Say So”
“Coalition Innovation Santé”: Servier supports Chronolife
New collaboration between Servier and the Autonomous University of Barcelona in Parkinson’s disease
“Coalition Innovation Santé”: Servier supports the start-up Cureety
Servier completes the acquisition of Symphogen
Golden Ticket 2020 awarded to Rgenta Therapeutics, a biotech specializing in diseases considered incurable
Final closing of the Kurma Biofund III fund